Overexpression of human β-defensin-3 in oral dysplasia: Potential role in macrophage trafficking

Oral Oncology

Volumn 45, Issue 8, 2009, Pages 696-702

  Kawsar, Hameem I ^a   Weinberg, Aaron ^a   Hirsch, Stanley A ^a   Venizelos, Andrea ^a   Howell, Scott ^b   Jiang, Bin ^a   Jin, Ge ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Defensins; hBD 3; Macrophage; Oral carcinoma

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; EPIDERMAL GROWTH FACTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; STAT3 PROTEIN;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER GROWTH; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MACROPHAGE; MITOSIS; MONOCYTE; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BETA-DEFENSINS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; HUMANS; MACROPHAGES; MICROSCOPY, FLUORESCENCE; MOUTH NEOPLASMS; PHOSPHOTRANSFERASES; PRECANCEROUS CONDITIONS; STAT TRANSCRIPTION FACTORS;

EID: 67650469499     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.10.016     Document Type: Article

References (53)

1. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 6636 (1997) 861
2. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., and Forssmann W.G. HBD-1: a novel beta-defensin from human plasma. FEBS Lett 368 2 (1995) 331-335
3. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 8 (2001) 5707-5713
4. Jurevic R.J., Bai M., Chadwick R.B., White T.C., and Dale B.A. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 41 1 (2003) 90-96
5. Dale B.A., Kimball J.R., Krisanaprakornkit S., Roberts F., Robinovitch M., O'Neal R., et al. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 36 5 (2001) 285-294
6. Yang D., Liu Z.H., Tewary P., Chen Q., de la Rosa G., and Oppenheim J.J. Defensin participation in innate and adaptive immunity. Curr Pharm Des 13 30 (2007) 3131-3139
7. Pazgier M., Hoover D.M., Yang D., Lu W., and Lubkowski J. Human beta-defensins. Cell Mol Life Sci 63 11 (2006) 1294-1313
8. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. beta-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 5439 (1999) 525-528
9. Niyonsaba F., Ogawa H., and Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111 3 (2004) 273-281
10. Soruri A., Grigat J., Forssmann U., Riggert J., and Zwirner J. beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 37 9 (2007) 2474-2486
11. Feng Z., Dubyak G.R., Lederman M.M., and Weinberg A. Cutting edge: human beta-defensin-3 - a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 177 2 (2006) 782-786
12. Funderburg N., Lederman M.M., Feng Z., Drage M.G., Jadlowsky J., Harding C.V., et al. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci USA 104 47 (2007) 18631-18635
13. Donald C.D., Sun C.Q., Lim S.D., Macoska J., Cohen C., Amin M.B., et al. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 83 4 (2003) 501-505
14. Meyer J.E., and Harder J. Antimicrobial peptides in oral cancer. Curr Pharm Des 13 30 (2007) 3119-3130
15. Choong N.W., and Cohen E.E. Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 57 1 (2006) 25-43
16. Choi S., and Myers J.N. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87 1 (2008) 14-32
17. Freier K., Joos S., Flechtenmacher C., Devens F., Benner A., Bosch F.X., et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63 6 (2003) 1179-1182
18. Holbro T., and Hynes N.E. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44 (2004) 195-217
19. Reuter C.W., Morgan M.A., and Eckardt A. Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Br J Cancer 96 3 (2007) 408-416
20. Henson E.S., and Gibson S.B. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18 12 (2006) 2089-2097
21. Prenzel N., Fischer O.M., Streit S., Hart S., and Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8 1 (2001) 11-31
22. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., and Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 20 (1996) 4625-4629
23. Himes R.H., Burton P.R., Kersey R.N., and Pierson G.B. Brain tubulin polymerization in the absence of "microtubule-associated proteins". Proc Natl Acad Sci USA 73 12 (1976) 4397-4399
24. Lissbrant I.F., Stattin P., Wikstrom P., Damber J.E., Egevad L., and Bergh A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17 3 (2000) 445-451
25. Hanada T., Nakagawa M., Emoto A., Nomura T., Nasu N., and Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7 7 (2000) 263-269
26. Salvesen H.B., and Akslen L.A. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84 5 (1999) 538-543
27. Liu S.Y., Chang L.C., Pan L.F., Hung Y.J., Lee C.H., and Shieh Y.S. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 44 3 (2008) 277-285
28. Marcus B., Arenberg D., Lee J., Kleer C., Chepeha D.B., Schmalbach C.E., et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 101 12 (2004) 2779-2787
29. Buettner M., Meyer B., Schreck S., and Niedobitek G. Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40. Int J Cancer 121 12 (2007) 2703-2710
30. Ferreira F.O., Ribeiro F.L., Batista A.C., Leles C.R., de Cassia Goncalves Alencar R., and Silva T.A. Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma. Tumour Biol 29 2 (2008) 114-121
31. Muramatsu H., Kogawa K., Tanaka M., Okumura K., Nishihori Y., Koike K., et al. Superoxide dismutase in SAS human tongue carcinoma cell line is a factor defining invasiveness and cell motility. Cancer Res 55 24 (1995) 6210-6214
32. Eicher S.A., Clayman G.L., Liu T.J., Shillitoe E.J., Storthz K.A., Roth J.A., et al. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin Cancer Res 2 10 (1996) 1659-1664
33. Krisanaprakornkit S., Kimball J.R., Weinberg A., Darveau R.P., Bainbridge B.W., and Dale B.A. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immunol 68 5 (2000) 2907-2915
34. Collins T.J. Image for microscopy. Biotechniques 43 Suppl. 1 (2007) 25-30
35. Bravo R. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163 2 (1986) 287-293
36. Ishida K., Ito S., Wada N., Deguchi H., Hata T., Hosoda M., et al. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer 6 62 (2007)
37. Croce C.M. Oncogenes and cancer. N Engl J Med 358 5 (2008) 502-511
38. Cambier J.C. Signal transduction by T- and B-cell antigen receptors: converging structures and concepts. Curr Opin Immunol 4 3 (1992) 257-264
39. Pulford K.A., Sipos A., Cordell J.L., Stross W.P., and Mason D.Y. Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 2 10 (1990) 973-980
40. Ramaswamy S., Nakamura N., Vazquez F., Batt D.B., Perera S., Roberts T.M., et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96 5 (1999) 2110-2115
41. Hocevar B.A., Brown T.L., and Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. Embo J 18 5 (1999) 1345-1356
42. Minden A., Lin A., McMahon M., Lange-Carter C., Derijard B., Davis R.J., et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266 5191 (1994) 1719-1723
43. Lu Q., Samaranayake L.P., Darveau R.P., and Jin L. Expression of human beta-defensin-3 in gingival epithelia. J Periodontal Res 40 6 (2005) 474-481
44. de Visser K.E., Eichten A., and Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6 1 (2006) 24-37
45. Biswas S.K., Sica A., and Lewis C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 180 4 (2008) 2011-2017
46. Allavena P., Sica A., Solinas G., Porta C., and Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66 1 (2008) 1-9
47. Huang S., Van Arsdall M., Tedjarati S., McCarty M., Wu W., Langley R., et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94 15 (2002) 1134-1142
48. Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 3 (2000) 481-490
49. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 10 9 (2004) 950-958
50. Wu Z., Hoover D.M., Yang D., Boulegue C., Santamaria F., Oppenheim J.J., et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin-3. Proc Natl Acad Sci USA 100 15 (2003) 8880-8885
51. Chen X., Niyonsaba F., Ushio H., Hara M., Yokoi H., Matsumoto K., et al. Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 37 2 (2007) 434-444
52. Boughan P.K., Argent R.H., Body-Malapel M., Park J.H., Ewings K.E., Bowie A.G., et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem 281 17 (2006) 11637-11648
53. Sorensen O.E., Thapa D.R., Roupe K.M., Valore E.V., Sjobring U., Roberts A.A., et al. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116 7 (2006) 1878-1885